Gap Junctions and Ageing
- PMID: 36600132
- DOI: 10.1007/978-3-031-21410-3_6
Gap Junctions and Ageing
Abstract
Gap junctions, comprising connexin proteins, create conduits directly coupling the cytoplasms of adjacent cells. Expressed in essentially all tissues, dynamic gap junction structures enable the exchange of small molecules including ions and second messengers, and are central to maintenance of homeostasis and synchronized excitability. With such diverse and critical roles throughout the body, it is unsurprising that alterations to gap junction and/or connexin expression and function underlie a broad array of age-related pathologies. From neurological dysfunction to cardiac arrhythmia and bone loss, it is hard to identify a human disease state that does not involve reduced, or in some cases inappropriate, intercellular communication to affect organ function. With a complex life cycle encompassing several key regulatory steps, pathological gap junction remodeling during ageing can arise from alterations in gene expression, translation, intracellular trafficking, and posttranslational modification of connexins. Connexin proteins are now known to "moonlight" and perform a variety of non-junctional functions in the cell, independent of gap junctions. Furthermore, connexin "hemichannels" on the cell surface can communicate with the extracellular space without ever coupling to an adjacent cell to form a gap junction channel. This chapter will focus primarily on gap junctions in ageing, but such non-junctional connexin functions will be referred to where appropriate and the full spectrum of connexin biology should be noted as potentially causative/contributing to some findings in connexin knockout animals, for example.
Keywords: Ageing; Connexin; Gap junction; Homeostasis; Intercellular communication.
© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.
References
-
- Adam O, Lavall D, Theobald K, Hohl M, Grube M, Ameling S, Sussman MA, Rosenkranz S, Kroemer HK, Schafers HJ, Bohm M, Laufs U (2010) Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol 55(5):469–480. https://doi.org/10.1016/j.jacc.2009.08.064 - DOI
-
- Agullo-Pascual E, Lin X, Leo-Macias A, Zhang M, Liang FX, Li Z, Pfenniger A, Lubkemeier I, Keegan S, Fenyo D, Willecke K, Rothenberg E, Delmar M (2014) Super-resolution imageing reveals that loss of the C-terminus of connexin43 limits microtubule plus-end capture and NaV1.5 localization at the intercalated disc. Cardiovasc Res 104(2):371–381. https://doi.org/10.1093/cvr/cvu195 - DOI
-
- Anderson C, Catoe H, Werner R (2006) MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 34(20):5863–5871. https://doi.org/10.1093/nar/gkl743 - DOI
-
- Anderson CL, Zundel MA, Werner R (2005) Variable promoter usage and alternative splicing in five mouse connexin genes. Genomics 85(2):238–244. https://doi.org/10.1016/j.ygeno.2004.11.007 - DOI
-
- Araujo PR, Yoon K, Ko D, Smith AD, Qiao M, Suresh U, Burns SC, Penalva LO (2012) Before it gets started: regulating translation at the 5' UTR. Comp Funct Genomics 2012:475731. https://doi.org/10.1155/2012/475731 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous